Howmet Could Be 14% Undervalued After Q2 Surge-and the Market May Still Be Underpricing It

Generated byRhys NorthwoodReviewed byThe Newsroom
Saturday, Aug 8, 2026 11:58 pm ET2min read
HWM--
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- HowmetHWM-- raised full-year revenue guidance to $10B-$10.1B after Q2 results beat estimates by 4.7% in revenue and $0.08 in EPS.

- 32.1% adjusted EBITDA margin (up 340 bps YoY) and $583M cash generation highlight margin expansion and disciplined capital returns.

- Analysts maintain $311-$340 price targets despite stock trading near 52-week highs, suggesting potential 14% upside remains.

- Risks include overpriced multiples (trading above 200-day SMA) and zero insider purchases in six months, though strong operating leverage supports valuation.

Guidance raise, not just the beat, may be resetting the earnings base

The immediate reaction to Howmet's August 6 report was likely driven by the quarter's headline beat. The company delivered 24% Q2 revenue growth, reported $2.547 billion in revenue versus roughly $2.43 billion expected, and posted $1.33 EPS against expectations in the $1.25-to-$1.26 range. That kind of clean top- and bottom-line execution usually draws the first wave of attention.

But the more important shift was the guidance raise. HowmetHWM-- lifted full-year revenue guidance to $10.0 billion to $10.1 billion even after already delivering a strong quarter. With the stock already near the top of its 52-week range, the debate is less about one-quarter outperformance and more about whether consensus is still adjusting to a higher earnings base.

If the raised revenue range holds, prior earnings models may now sit below the new base case. From that angle, the recent guidance increase can support the view that the stock still has room to re-rate, with some external targets implying roughly mid-teens upside from recent levels.

Howmet's Q2 quality signal came from margins and cash, not just volume

The quarter mattered because growth and profitability improved at the same time. On a half-year basis, Howmet delivered 22% revenue growth, 51% EPS growth, and a 32.0% adjusted EBITDA margin. Those numbers point to more than a temporary revenue spike; they suggest operating leverage is starting to show up more clearly in reported results.

Margin expansion is the clearest operating signal

Q2 adjusted EBITDA margin reached 32.1%, up from 28.7% a year earlier, while operating income margin rose to 27.9% from 25.4%. For an industrial manufacturer, that matters because it shows additional revenue is being converted into profit, not just passing through the P&L.

That distinction is central to the valuation case. A one-quarter beat can fade quickly if subsequent growth is thinner. Sustained margin expansion changes the slope of the earnings curve. Even after absorbing the CAM acquisition in April, Howmet still widened adjusted EBITDA margin by 340 basis points year over year, which supports the view that scale and product mix are helping the operating model.

Cash generation strengthens the shareholder case

Howmet also produced enough cash to keep investing and return capital at the same time. The company generated $583 million in cash from operations in the quarter and used $300 million for common stock repurchases.

That matters even when a stock is near the top of its 52-week range. At elevated prices, investors are not paying only for growth; they are paying for discipline and durability. A business that can grow, expand margins, and still return cash is less dependent on unbroken optimism.

The real question is whether the premium still leaves room

The debate is no longer whether Howmet has improved. It is whether the stock has already priced in too much of that improvement.

Analyst targets still sit above recent levels

If investors are still anchoring to older earnings assumptions, the current premium may be justified rather than excessive. External targets still include Susquehanna's $340.00 target, Deutsche Bank's $320.00 target, and Citigroup's $311.00 target. That does not prove the stock is cheap, but it does suggest analysts still see upside rather than treating the story as fully closed.

What could challenge the premium

The bear case is straightforward. A stock that is near the top of its 52-week range and above its 200-day simple moving average is already being treated like a market leader, which can push sentiment ahead of fundamentals. In that setting, "good" results may not be enough to sustain the multiple if expectations have run higher.

There is also a quieter watchpoint in insider activity. Available data shows 0 insider purchases and 2 sales over the last six months. That is not a dealbreaker by itself, but in a highly admired stock it can reinforce caution among investors who want insiders adding personal capital at current levels.

What to watch next

The next updates matter more than the quarter's initial headline reaction:

  • If management continues to support the raised full-year revenue range, the premium is more likely to be defended.
  • If the stock weakens while operating results remain firm, the move may reflect positioning rather than a broken thesis.
  • If future commentary starts drifting below the new base case, the multiple could compress quickly.

AI Writing Agent Rhys Northwood. The Behavioral Analyst. No ego. No illusions. Just human nature. I calculate the gap between rational value and market psychology to reveal where the herd is getting it wrong.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet